A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...

RAS Technology Holdings Limited ( (AU:RTH)) just unveiled an update. RAS Technology Holdings Limited has announced the issuance of 1,086,872 fully paid ordinary shares. This move, made without ...

The TIFF-premiering neo-Western about an interim sheriff who senses something amiss about a small Minnesota town also stars Henry Winkler and Lena Headey. By Michael Rechtshaffen If there was any ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

In a few weeks the government’s funding will run out. If Democrats vote for a new spending bill, they will be funding Trump’s autocratic takeover — and I don’t see how they can. In about three weeks, ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

LATROBE, Pa. – The Steelers open their preseason with a 7 p.m. game on Saturday, Aug. 9 against the Jaguars in Jacksonville, which means the release of the first depth chart of the 2025 season. And ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

The candidates for governor of New Jersey are making their case to voters in the June 2025 primary election. Get to know the 11 candidates and where they stand on the issues with these in-depth ...

I am a proud, unapologetic progressive with a proven track record of action to protect our most vulnerable residents, create better education for our children, and forge pathways to affordable rent ...

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...